{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T09:43:32Z","timestamp":1778406212745,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki Rzeczypospolitej Polskiej","doi-asserted-by":"publisher","award":["DEC-2017\/01\/X\/NZ7\/00931"],"award-info":[{"award-number":["DEC-2017\/01\/X\/NZ7\/00931"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005992","name":"Ministry of Education and Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005992","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.dmpk.2023.100493","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T02:10:53Z","timestamp":1675476653000},"page":"100493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Bioavailability of tetracyclines is substantially increased by administration of cyclosporine A, a non-specific efflux-pump blocker"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9314-8666","authenticated-orcid":false,"given":"Hubert","family":"Zi\u00f3\u0142kowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2023.100493_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1368-7646(02)00051-1","article-title":"New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors","volume":"5","author":"Chopra","year":"2002","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.dmpk.2023.100493_bib2","first-page":"46","article-title":"Hematic levels of meclocycline in adults treated with meclocycline ointment","volume":"10","author":"Gattini","year":"1972","journal-title":"Antibiotica"},{"key":"10.1016\/j.dmpk.2023.100493_bib3","series-title":"Oral formulation comprising tigecycline","author":"Diorio","year":"2008"},{"key":"10.1016\/j.dmpk.2023.100493_bib4","first-page":"789","article-title":"Tetracyclines","volume":"79","author":"Klein","year":"1995","journal-title":"Med Clin"},{"key":"10.1016\/j.dmpk.2023.100493_bib5","first-page":"225","article-title":"USP veterinary pharmaceutical information monographs \u2013 antibiotics: Tetracyclines","volume":"26","author":"Riviere","year":"2003","journal-title":"J\u00a0Vet Pharmacol Ther Suppl 2"},{"key":"10.1016\/j.dmpk.2023.100493_bib6","first-page":"625","article-title":"Drug diffusion and bioavailability: tetracycline metallic chelation","volume":"32","author":"Chin","year":"1975","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.dmpk.2023.100493_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/AAC.26.2.263","article-title":"Tetracycline diffusion through phospholipid bilayers and binding to phospholipids","volume":"26","author":"Argast","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.dmpk.2023.100493_bib8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/AAC.37.7.1393","article-title":"Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples","volume":"37","author":"Nikaido","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.dmpk.2023.100493_bib9","first-page":"253","article-title":"The passage of tetracyclines across epithelial membranes with special reference to prostatic epithelium","volume":"106","author":"Hessl","year":"1971","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.dmpk.2023.100493_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/00003495-200464010-00005","article-title":"The glycylcyclines: a comparative review with the tetracyclines","volume":"64","author":"Zhanel","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.dmpk.2023.100493_bib11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1432-1327.2000.01026.x","article-title":"Permeation of tetracyclines through membranes of liposomes and Escherichia coli","volume":"267","author":"Sigler","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.dmpk.2023.100493_bib12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/AAC.8.6.713","article-title":"Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs","volume":"8","author":"Barza","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.dmpk.2023.100493_bib13","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1016\/j.psj.2020.06.038","article-title":"Comparative pharmacokinetics of chlortetracycline, tetracycline, minocycline, and tigecycline in broiler chickens","volume":"99","author":"Zi\u00f3\u0142kowski","year":"2020","journal-title":"Poultry Sci"},{"key":"10.1016\/j.dmpk.2023.100493_bib14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.dmpk.2023.100493_bib15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/jac\/dkg224","article-title":"Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy","volume":"51","author":"Van Bambeke","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.dmpk.2023.100493_bib16","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/jac\/dkg225","article-title":"Antibiotic efflux pumps in eukaryotic cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics","volume":"51","author":"Van Bambeke","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.dmpk.2023.100493_bib17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.biochem.71.102301.093055","article-title":"Mammalian ABC transporters in health and disease","volume":"71","author":"Borst","year":"2002","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.dmpk.2023.100493_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1993.1013","article-title":"Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells","volume":"190","author":"Kavallaris","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dmpk.2023.100493_bib19","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1016\/0006-2952(88)90294-8","article-title":"Reduced cytotoxicity of tetracyclines to a multi-drug resistant human cell line","volume":"37","author":"Grandi","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dmpk.2023.100493_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2885.2007.00808.x","article-title":"P-glycoprotein-mediated transport of oxytetracycline in the Caco-2 cell model","volume":"30","author":"Schrickx","year":"2007","journal-title":"J\u00a0Vet Pharmacol Therapeut"},{"key":"10.1016\/j.dmpk.2023.100493_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.rvsc.2010.01.005","article-title":"Expression of drug efflux transporters in poultry tissues","volume":"89","author":"Haritova","year":"2010","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.dmpk.2023.100493_bib22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF01972366","article-title":"Cyclosporine: immunology, toxicity and pharmacology in experimental animals","volume":"15","author":"Thomson","year":"1984","journal-title":"Agents Actions"},{"key":"10.1016\/j.dmpk.2023.100493_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/B:DRUG.0000026248.45084.21","article-title":"Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice","volume":"22","author":"Bardelmeijer","year":"2004","journal-title":"Invest N Drugs"},{"key":"10.1016\/j.dmpk.2023.100493_bib24","series-title":"Drug development and drug interactions","author":"Fda","year":"2020"},{"key":"10.1016\/j.dmpk.2023.100493_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tvjl.2015.08.022","article-title":"Pharmacokinetics of oxytetracycline in broiler chickens following different routes of administration","volume":"208","author":"Zi\u00f3\u0142kowski","year":"2016","journal-title":"Vet J"},{"key":"10.1016\/j.dmpk.2023.100493_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01117450","article-title":"Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations","volume":"6","author":"Yamaoka","year":"1978","journal-title":"J\u00a0Pharmacokinet Biopharm"},{"key":"10.1016\/j.dmpk.2023.100493_bib27","series-title":"Pharmacokinetics","first-page":"409","article-title":"Noncompartmental analysis based on statistical moment theory","author":"Gibaldi","year":"1982"},{"key":"10.1016\/j.dmpk.2023.100493_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.rvsc.2014.05.005","article-title":"Influence of oral coadministration of a preparation containing calcium and magnesium and food on enrofloxacin pharmacokinetics","volume":"97","author":"Zi\u00f3\u0142kowski","year":"2014","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.dmpk.2023.100493_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1081\/BIP-100101013","article-title":"Why are pharmacokinetic data summarized by arithmetic means?","volume":"10","author":"Julious","year":"2000","journal-title":"J\u00a0Biopharm Stat"},{"key":"10.1016\/j.dmpk.2023.100493_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J\u00a0R Stat Soc Ser B"},{"key":"10.1016\/j.dmpk.2023.100493_bib32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0002-9343(90)90429-H","article-title":"Cyclosporine-induced changes in glomerular filtration rate and urea excretion","volume":"88","author":"Laskow","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.dmpk.2023.100493_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0169-409X(97)00043-4","article-title":"Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery","volume":"27","author":"Hebert","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.dmpk.2023.100493_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0378-4347(97)00644-0","article-title":"Liquid chromatographic separation of doxycycline and 4-epidoxycycline in a tissue depletion study of doxycycline in turkeys","volume":"708","author":"Croubels","year":"1998","journal-title":"J\u00a0Chromatogr B"},{"key":"10.1016\/j.dmpk.2023.100493_bib35","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1021\/jf000141k","article-title":"Metabolites of oxytetracycline, tetracycline, and chlortetracycline and their distribution in egg white, egg yolk, and hen plasma","volume":"48","author":"Zurhelle","year":"2000","journal-title":"J\u00a0Agric Food Chem"},{"key":"10.1016\/j.dmpk.2023.100493_bib36","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1124\/dmd.107.015735","article-title":"Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects","volume":"35","author":"Hoffmann","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2023.100493_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0022-3565(25)38687-8","article-title":"Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats","volume":"269","author":"Colombo","year":"1994","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.dmpk.2023.100493_bib38","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s11095-012-0918-y","article-title":"Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters: application of PBPK modeling in the assessment of drug-drug interaction potential","volume":"30","author":"Gertz","year":"2013","journal-title":"Pharm Res (N Y)"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436723000058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436723000058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:56:54Z","timestamp":1761163014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436723000058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":37,"alternative-id":["S1347436723000058"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2023.100493","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioavailability of tetracyclines is substantially increased by administration of cyclosporine A, a non-specific efflux-pump blocker","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2023.100493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100493"}}